BioAge Labs, Inc. (BIOA)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited StatesUS09077V1008
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by BioAge Labs, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:01. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Mar 2027 17:00 | -0.73 | — | — | Upcoming |
| 05 Nov 2026 16:00 | -0.63 | -0.73 | -16.6% | Miss |
| 05 Aug 2026 16:00 | -0.62 | -0.58 | +7.1% | Beat |
| 08 May 2026 09:00 | -0.63 | -0.52 | +17.1% | Beat |
| 24 Mar 2026 09:00 | -0.67 | -0.72 | -7.7% | Miss |
| 06 Nov 2025 16:00 | -0.51 | -0.56 | -9.0% | Miss |
| 06 Aug 2025 16:00 | -0.38 | -0.60 | -57.3% | Miss |
| 06 May 2025 16:00 | -0.53 | -0.36 | +31.8% | Beat |
| 20 Mar 2025 17:00 | -0.66 | -1.75 | -167.8% | Miss |
| 07 Nov 2024 16:00 | -0.73 | -6.70 | -812.5% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 9M | — | -80.6M | -896.1% | -2.24 | +66.2% | -82.3M |
| 2024 | 0 | — | -71.1M | — | -6.63 | -108.9% | -51.9M |
| 2023 | 0 | — | -63.9M | — | -3.17 | +86.6% | -37.5M |
| 2022 | 0 | — | -39.7M | — | -23.76 | — | -36.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 5.36 | 6.08 | 5.16 | 5.43 | +1.69% | 2,324,495 | |
| 02 Nov 2026 – 06 Nov 2026 | 6.00 | 6.30 | 5.24 | 5.34 | -9.03% | 3,517,700 | |
| 26 Oct 2026 – 30 Oct 2026 | 5.10 | 6.26 | 4.92 | 5.87 | +15.10% | 4,728,500 | |
| 19 Oct 2026 – 23 Oct 2026 | 4.84 | 5.70 | 4.82 | 5.10 | +5.37% | 3,964,800 | |
| 12 Oct 2026 – 16 Oct 2026 | 6.24 | 6.30 | 4.81 | 4.84 | -23.66% | 3,414,800 | |
| 05 Oct 2026 – 09 Oct 2026 | 6.65 | 6.68 | 5.99 | 6.34 | -4.08% | 6,406,600 | |
| 28 Sep 2026 – 02 Oct 2026 | 7.11 | 7.43 | 6.47 | 6.61 | -6.24% | 3,440,900 | |
| 21 Sep 2026 – 25 Sep 2026 | 8.07 | 8.53 | 7.03 | 7.05 | -12.53% | 4,114,100 | |
| 14 Sep 2026 – 18 Sep 2026 | 8.52 | 8.64 | 7.62 | 8.06 | -5.06% | 4,371,800 | |
| 08 Sep 2026 – 11 Sep 2026 | 9.60 | 9.65 | 8.28 | 8.49 | -11.47% | 2,041,100 | |
| 102 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- BioAge Labs to Present at Upcoming Investor Conferences (opens in a new tab) 11 Nov 2026 13:00
- Piper Sandler Maintains Overweight on Bioage Labs, Lowers Price Target to $40 (opens in a new tab) Benzinga · 09 Nov 2026 13:09
- BTIG Reiterates Buy on Bioage Labs, Maintains $40 Price Target (opens in a new tab) Benzinga · 09 Nov 2026 06:16
- BioAge Labs, Inc. (BIOA) Reports Q3 Loss, Misses Revenue Estimates (opens in a new tab) Zacks · 05 Nov 2026 21:45
- BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates (opens in a new tab) 05 Nov 2026 21:30
- Bioage Labs Q3 EPS $(0.73) Misses $(0.59) Estimate, Sales $298.000K Miss $1.644M Estimate (opens in a new tab) Benzinga · 05 Nov 2026 17:56
- Earnings Preview: BioAge Labs, Inc. (BIOA) Q3 Earnings Expected to Decline (opens in a new tab) Zacks · 29 Oct 2026 13:00
- BioAge Labs' Lead Drug Faces Uncertain Path as Data Looms, UBS Says (opens in a new tab) MT Newswires · 12 Oct 2026 18:02
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 5.65 USD
- Market cap
- 249.5M
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow BIOA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.